ArticleEvidence-based complementary and alternative medicine : eCAM2022

Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution.

Runze Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.